Target RWE generates real-world evidence (RWE) that informs strategic decisions across the drug development lifecycle. Our unique combination of clinical, analytical and technical expertise enables ...

Discover how even low intensity smoking raises long term heart risks. Keep reading to learn why quitting early matters.

USA: Researchers have found in a new study that Evolocumab reduces cardiac events in high-risk patients without prior ...

Older adults hospitalized with infections had a significantly higher risk of developing dementia, according to an October study published in Aging-US.

NEW ORLEANS -- Adding the PCSK9 inhibitor evolocumab (Repatha) to stable lipid-lowering therapy reduced major adverse cardiac events (MACE) in patients with atherosclerosis or high-risk diabetes, but ...

Key points A 56-year-old woman presented to the emergency department with a 2-day history of central chest pain and dyspnea. Her medical history included having had a myocardial infarction (MI) with n ...

People with cardiovascular disease (i.e. affecting the heart and blood vessels) who use low-dose colchicine for at least six months will reduce their risk of myocardial infarction (heart attack) and ...

Argenica Therapeutics has taken a step forward in the development of its neuroprotective drug candidate ARG-007 in acute ...

A low dose of colchicine — a commonly used gout drug — helped reduce the risk of heart attack and stroke in people with ...

New data raise the question of whether statins increase cardiovascular or cerebrovascular hospitalizations in dementia, but ...

LDL cholesterol level < 40 vs ≥ 70 mg/dL is linked to lower rates of future major cardiovascular events in patients with ischemic stroke, without increasing the risk for hemorrhagic stroke.

Professor Nam Hyo-seok of the Department of Neurology at Severance Hospital led to the recently announced revision of the ...